US Patent 10292987 Heterocyclic amides as kinase inhibitors
Patent 10292987 was granted and assigned to GlaxoSmithKline on May, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10292987 Heterocyclic amides as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.